- Home
- MDXH vs SOL Comparison
MDXH vs SOL Comparison
Compare MDXH & SOL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MDXH
- SOL
- Stock Information
- Founded
- MDXH 2003
- SOL 2005
- Country
- MDXH Belgium
- SOL United States
- Employees
- MDXH N/A
- SOL N/A
- Industry
- MDXH
- SOL Semiconductors
- Sector
- MDXH
- SOL Technology
- Exchange
- MDXH Nasdaq
- SOL Nasdaq
- Market Cap
- MDXH 100.5M
- SOL 109.2M
- IPO Year
- MDXH 2021
- SOL 2008
- Fundamental
- Price
- MDXH $1.77
- SOL $2.00
- Analyst Decision
- MDXH Strong Buy
- SOL Buy
- Analyst Count
- MDXH 2
- SOL 3
- Target Price
- MDXH $7.00
- SOL $3.83
- AVG Volume (30 Days)
- MDXH 98.8K
- SOL 218.5K
- Earning Date
- MDXH 11-06-2024
- SOL 11-14-2024
- Dividend Yield
- MDXH N/A
- SOL N/A
- EPS Growth
- MDXH N/A
- SOL N/A
- EPS
- MDXH N/A
- SOL N/A
- Revenue
- MDXH $84,708,000.00
- SOL $103,577,000.00
- Revenue This Year
- MDXH $26.39
- SOL $44.70
- Revenue Next Year
- MDXH $18.68
- SOL $20.53
- P/E Ratio
- MDXH N/A
- SOL N/A
- Revenue Growth
- MDXH 33.01
- SOL 7.56
- 52 Week Low
- MDXH $0.35
- SOL $1.41
- 52 Week High
- MDXH $4.64
- SOL $3.00
- Technical
- Relative Strength Index (RSI)
- MDXH 26.20
- SOL 34.81
- Support Level
- MDXH $1.62
- SOL $2.00
- Resistance Level
- MDXH $2.24
- SOL $2.18
- Average True Range (ATR)
- MDXH 0.13
- SOL 0.15
- MACD
- MDXH -0.01
- SOL -0.06
- Stochastic Oscillator
- MDXH 28.57
- SOL 0.00
About MDXH MDxHealth SA
MDxHealth SA is a multinational healthcare company that provides actionable molecular diagnostic information to personalize the diagnosis and treatment of cancer. Its tests are based on proprietary genomic, epigenetic, and other molecular technologies and assist physicians with the diagnosis of urologic cancers, the prognosis of recurrence risk, and prediction of response to a specific therapy. It derives revenues from clinical laboratory service testing or the out-licensing of the company's patented DNA methylation platform and biomarkers. Geographically, it derives revenue from the United States of America (USA), and Europe.
About SOL Emeren Group Ltd each representing 10 shares
Emeren Group Ltd is a renewable energy producer. Its portfolio consists of solar projects and Independent Power Producer (IPP) assets, and it also has global Battery Energy Storage System (BESS) capacity. The group specializes in the solar project lifecycle, development, and from construction to financing. It has three reportable segments; Solar power project development, EPC services, and Electricity generation. The company generates maximum revenue from Poland.